Page 5 - Precision Medicine Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sidra Medicine researchers publish study on antibodies against coronavirus infection  23 Feb 2021 - 12:32 The Peninsula Doha: A team of researchers from Sidra Medicine have published a study about antibody responses against ‘common cold’ coronaviruses involving over a thousand individuals. The study is featured in the February 22 issue of JCI Insight, a peer-reviewed medical journal. Dr Nico Marr, principal investigator and group leader who led the study at Sidra Medicine, explained: “Antibodies play a crucial part in our body’s defense against infectious diseases, such as COVID-19...

Imperial Valley News Pressing all envelopes

 at Henry Ford Health System . “Through global collaboration, GBM AGILE is making it possible for some of the world’s foremost experts in glioblastoma research and treatment to collaborate and advance the pace at which scientific and clinical breakthroughs can be achieved.” After opening at Henry Ford Cancer Institute, the two new interventions –   VAL-083   from Kintara Therapeutics, Inc.  and   paxalisib   from Kazia Therapeutics Limited– will subsequently open at more than 35 trial sites across the United States, with additional global sites in Canada, Europe and ...

DBusiness Magazine Henry Ford Health System First in World to Test Treatments for Brain Cancer Detroit-based Henry Ford Cancer Institute has announced it is the first site in the world to activate two treatments for glioblastoma, the deadliest form of brain cancer, as part of a patient-centered adaptive platform trial called GBM AGILE. Henry Ford Cancer Institute is the first on the planet to active two treatments for the deadliest form of brain cancer. // Photo courtesy of Henry Ford Health System Detroit-based Henry Ford Cancer Institute has announced it is the first site in the world to ac...

 E-Mail IMAGE: Tom Mikkelsen, M.D., principal investigator for GBM AGILE at Henry Ford Cancer Institute, and medical director of the Precision Medicine Program and Clinical Trials Office at Henry Ford Health System.... view more  Credit: Henry Ford Health System DETROIT (Feb. 3, 2021) - Henry Ford Cancer Institute is the first site in the world to activate two new treatments for glioblastoma (GBM), the deadliest form of brain cancer, as part of a patient-centered adaptive platform trial known as GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment). Led by Global ...